Literature DB >> 19649653

Systems biology approach to identification of biomarkers for metastatic progression in gastric cancer.

Yuan-Yu Wang1, Zai-Yuan Ye, Zhong-Sheng Zhao, Hou-Quan Tao, Shu-Guang Li.   

Abstract

PURPOSE: Gastric cancer is usually diagnosed at later stages (stages III and IV) in China, and the overall 5-year survival rate is low at 40%. Metastases are responsible for the majority of cancer fatalities. The molecular mechanisms governing metastasis are poorly understood.
METHODS: We have analyzed gene expression data based on gene interaction networks and molecular pathways rather than separate genes utilizing hierarchical cluster analysis, Gene ontology analysis and pathway analysis.
RESULTS: We have analyzed gene expression data from advanced gastric cancer tissues, corresponding adjacent noncancerous gastric tissues and its peritonium metastasis. Our studies indicated that metastatic tumor was related to changes in apoptosis pathway and proteasome degradation pathway, TRAF2 and IRF3 are up-regulated in apoptosis pathway, NEDD4 and UBE1 are up-regulated in proteasome degradation pathway.
CONCLUSION: The advent of high-throughput investigation of gene using Microarray technology, a systems approach relying on groups of interacting genes is essential for understanding the processes of cancer. We have identified apoptosis pathway and proteasome degradation pathway associated with metastasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19649653     DOI: 10.1007/s00432-009-0644-y

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  24 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Functional discovery via a compendium of expression profiles.

Authors:  T R Hughes; M J Marton; A R Jones; C J Roberts; R Stoughton; C D Armour; H A Bennett; E Coffey; H Dai; Y D He; M J Kidd; A M King; M R Meyer; D Slade; P Y Lum; S B Stepaniants; D D Shoemaker; D Gachotte; K Chakraburtty; J Simon; M Bard; S H Friend
Journal:  Cell       Date:  2000-07-07       Impact factor: 41.582

3.  A molecular signature of metastasis in primary solid tumors.

Authors:  Sridhar Ramaswamy; Ken N Ross; Eric S Lander; Todd R Golub
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

4.  Nedd4-2 induces endocytosis and degradation of proteolytically cleaved epithelial Na+ channels.

Authors:  Rajesh Kabra; Kristin K Knight; Ruifeng Zhou; Peter M Snyder
Journal:  J Biol Chem       Date:  2008-01-03       Impact factor: 5.157

5.  Group testing for pathway analysis improves comparability of different microarray datasets.

Authors:  Theodora Manoli; Norbert Gretz; Hermann-Josef Gröne; Marc Kenzelmann; Roland Eils; Benedikt Brors
Journal:  Bioinformatics       Date:  2006-08-07       Impact factor: 6.937

6.  NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN.

Authors:  Xinjiang Wang; Lloyd C Trotman; Theresa Koppie; Andrea Alimonti; Zhenbang Chen; Zhonghua Gao; Junru Wang; Hediye Erdjument-Bromage; Paul Tempst; Carlos Cordon-Cardo; Pier Paolo Pandolfi; Xuejun Jiang
Journal:  Cell       Date:  2007-01-12       Impact factor: 41.582

7.  CD95 and TRAF2 promote invasiveness of pancreatic cancer cells.

Authors:  Anna Trauzold; Christian Röder; Bence Sipos; Kristin Karsten; Alexander Arlt; Ping Jiang; Jose Ignacio Martin-Subero; Daniela Siegmund; Susanne Müerköster; Laia Pagerols-Raluy; Reiner Siebert; Harald Wajant; Holger Kalthoff
Journal:  FASEB J       Date:  2005-01-24       Impact factor: 5.191

8.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

9.  Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging.

Authors:  Jianping Jin; Xue Li; Steven P Gygi; J Wade Harper
Journal:  Nature       Date:  2007-06-28       Impact factor: 49.962

10.  Grb10 prevents Nedd4-mediated vascular endothelial growth factor receptor-2 degradation.

Authors:  Joseph Murdaca; Caroline Treins; Marie-Noëlle Monthouël-Kartmann; Rodolphe Pontier-Bres; Sharad Kumar; Emmanuel Van Obberghen; Sophie Giorgetti-Peraldi
Journal:  J Biol Chem       Date:  2004-04-01       Impact factor: 5.157

View more
  10 in total

1.  miR-152 suppresses gastric cancer cell proliferation and motility by targeting CD151.

Authors:  Ronglin Zhai; Xuefeng Kan; Bo Wang; Hansong Du; Yueping Long; Heshui Wu; Kaixiong Tao; Guobin Wang; Lihong Bao; Fen Li; Wanli Zhang
Journal:  Tumour Biol       Date:  2014-08-15

2.  Identification and functional characterization of long non-coding RNAs in human gastric cancer.

Authors:  Cheng-Yun Li; Ge-Yu Liang; Wen-Zhuo Yao; Jing Sui; Xian Shen; Yan-Qiu Zhang; Shu-Mei Ma; Yan-Cheng Ye; Zhi-Yi Zhang; Wen-Hua Zhang; Li-Hong Yin; Yue-Pu Pu
Journal:  Oncol Lett       Date:  2018-03-28       Impact factor: 2.967

3.  Upregulated INHBA expression is associated with poor survival in gastric cancer.

Authors:  Quan Wang; Yu-Gang Wen; Da-Peng Li; Jun Xia; Chong-Zhi Zhou; Dong-Wang Yan; Hua-Mei Tang; Zhi-Hai Peng
Journal:  Med Oncol       Date:  2010-12-04       Impact factor: 3.064

4.  Up-regulation of ECT2 is associated with poor prognosis in gastric cancer patients.

Authors:  Yi Jin; Yuhui Yu; Qinshu Shao; Yingyu Ma; Ruxuan Zhang; Haibo Yao; Yuan Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

Review 5.  Targeting the ubiquitin pathway for cancer treatment.

Authors:  Jia Liu; Shavali Shaik; Xiangpeng Dai; Qiong Wu; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-12-04

6.  Clinical significance of ECT2 expression in tissue and serum of gastric cancer patients.

Authors:  H-B Wang; H-C Yan; Y Liu
Journal:  Clin Transl Oncol       Date:  2015-10-26       Impact factor: 3.405

Review 7.  NEDD4: a promising target for cancer therapy.

Authors:  Xiantao Ye; Lixia Wang; Bingxue Shang; Zhiwei Wang; Wenyi Wei
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

8.  Identification of differentially-expressed genes in intestinal gastric cancer by microarray analysis.

Authors:  Shizhu Zang; Ruifang Guo; Rui Xing; Liang Zhang; Wenmei Li; Min Zhao; Jingyuan Fang; Fulian Hu; Bin Kang; Yonghong Ren; Yonglong Zhuang; Siqi Liu; Rong Wang; Xianghong Li; Yingyan Yu; Jing Cheng; Youyong Lu
Journal:  Genomics Proteomics Bioinformatics       Date:  2014-12-11       Impact factor: 7.691

9.  Copy number variation of E3 ubiquitin ligase genes in peripheral blood leukocyte and colorectal cancer.

Authors:  Haoran Bi; Tian Tian; Lin Zhu; Haibo Zhou; Hanqing Hu; Yanhong Liu; Xia Li; Fulan Hu; Yashuang Zhao; Guiyu Wang
Journal:  Sci Rep       Date:  2016-07-15       Impact factor: 4.379

10.  Overexpression of CD151 predicts prognosis in patients with resected gastric cancer.

Authors:  Yue-Ming Yang; Zhong-Wei Zhang; Qing-Meng Liu; Yi-Feng Sun; Ji-Ren Yu; Wei-Xing Xu
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.